Brenda was diagnosed with breast cancer in October 2017 and started a treatment plan that included chemotherapy. Her medical center offered scalp cooling to prevent hair loss. Here, Brenda discusses her results from scalp cooling and what they mean for her.
Experimental Pyrotinib and Xeloda Regimen Better Than Tykerb and Xeloda for Metastatic HER2-Positive Breast Cancer
The experimental anti-HER2 medicine pyrotinib plus the chemotherapy medicine Xeloda (chemical name: capecitabine) offered better progression-free survival than the anti-HER2 medicine Tykerb (chemic...